Literature DB >> 10541586

Molecular genetics and biology of inherited peripheral neuropathies: a fast-moving field.

E Nelis1, V Timmerman, P De Jonghe, C Van Broeckhoven, B Rautenstrauss.   

Abstract

The recent progress of molecular genetics has considerably increased our knowledge about the underlying disease mechanism of inherited peripheral neuropathies. Mutations in three genes coding for the myelin proteins peripheral myelin protein 22, myelin protein zero and connexin 32 and in one gene coding for the transcription factor early growth response 2 element are associated with Charcot-Marie-Tooth type 1 and 2, hereditary neuropathy with liability to pressure palsies, Dejerine-Sottas syndrome and congenital hypomyelination. This review focuses on the correlation of the different human phenotypes associated with distinct mutations with those found in cellular and animal models.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541586     DOI: 10.1007/s100480050074

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  7 in total

1.  A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3.

Authors:  A Leal; B Morera; D Heuss; C Kayser; M Berghoff; R Villegas; E Hernández; M Méndez; H C Hennies; B Neundörfer; R Barrantes; A Reis; B Rautenstrauss
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

Review 2.  Neuropathology of Charcot-Marie-Tooth and related disorders.

Authors:  J Michael Schröder
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Homozygous inactivation of the LGI1 gene results in hypomyelination in the peripheral and central nervous systems.

Authors:  Jeane Silva; Suash Sharma; Bernard Hughes; Y Eugene Yu; John K Cowell
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

Review 4.  The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy.

Authors:  Cornelius F Boerkoel; Hiroshi Takashima; James R Lupski
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

5.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

6.  Tracing myelin protein zero (P0) in vivo by construction of P0-GFP fusion proteins.

Authors:  Arif B Ekici; Sevinc Oezbey; Christina Fuchs; Eva Nelis; Christine Van Broeckhoven; Melitta Schachner; Bernd Rautenstrauss
Journal:  BMC Cell Biol       Date:  2002-11-26       Impact factor: 4.241

7.  The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy.

Authors:  Christina DiVincenzo; Christopher D Elzinga; Adam C Medeiros; Izabela Karbassi; Jeremiah R Jones; Matthew C Evans; Corey D Braastad; Crystal M Bishop; Malgorzata Jaremko; Zhenyuan Wang; Khalida Liaquat; Carol A Hoffman; Michelle D York; Sat D Batish; James R Lupski; Joseph J Higgins
Journal:  Mol Genet Genomic Med       Date:  2014-08-21       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.